The results showed that CD4+CD25+ Treg from both groups equally suppressed disease progression in adoptive transfer colitis models, as evidenced by similarly reduced weight loss (Figure 7B) and ameliorated colonic lesions (Figure 7C). The gene discussed is CD4; the disease is colitis.